| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 43.422 | - | 31.160 | 46.302 | 46.923 | - | - |
| Total Income - EUR | - | - | - | 43.422 | - | 31.161 | 46.302 | 46.923 | - | - |
| Total Expenses - EUR | - | - | - | 4.526 | - | 7.677 | 9.004 | 7.425 | - | - |
| Gross Profit/Loss - EUR | - | - | - | 38.896 | - | 23.484 | 37.297 | 39.498 | - | - |
| Net Profit/Loss - EUR | - | - | - | 37.593 | - | 22.549 | 35.908 | 38.357 | - | - |
| Employees | - | - | - | 0 | - | 0 | 0 | 1 | - | - |
Check the financial reports for the company - Dr. Natal Life S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 953 | - | 547 | 535 | 537 | - | - |
| Current Assets | - | - | - | 37.671 | - | 103.538 | 137.792 | 206.251 | - | - |
| Inventories | - | - | - | 0 | - | 0 | 0 | 0 | - | - |
| Receivables | - | - | - | 0 | - | 3.208 | 3.120 | 31.694 | - | - |
| Cash | - | - | - | 37.671 | - | 100.331 | 134.672 | 174.556 | - | - |
| Shareholders Funds | - | - | - | 37.636 | - | 98.649 | 132.370 | 38.406 | - | - |
| Social Capital | - | - | - | 43 | - | 41 | 40 | 41 | - | - |
| Debts | - | - | - | 988 | - | 5.437 | 5.958 | 168.382 | - | - |
| Income in Advance | - | - | - | 0 | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Natal Life S.r.l.